TipRanks
Nurix Therapeutics (NRIX)
NASDAQ:NRIX
US Market
NRIX
Nurix Therapeutics
RESEARCH TOOLSreports
Want to see NRIX full AI Analyst Report?

Nurix Therapeutics (NRIX) Stock News & Sentiment

596 Followers
Nurix Advances NX-5948 Combo Trial in B-Cell Cancers, Setting Up Key Catalyst for NRIX
Premium
Company Announcements
Nurix Advances NX-5948 Combo Trial in B-Cell Cancers, Setting Up Key Catalyst for NRIX
1M ago
NRIX
Is NRIX a Buy, Before Earnings?
Premium
Pre-Earnings
Is NRIX a Buy, Before Earnings?
3M ago
NRIX
Nurix Maintained at Buy as Bexobrutideg Data Underscore Safety Edge; $34 Price Target Reaffirmed
Premium
Ratings
Nurix Maintained at Buy as Bexobrutideg Data Underscore Safety Edge; $34 Price Target Reaffirmed
4M ago
NRIX
Nurix Highlights Promising Phase 1b Data for Bexobrutideg
Premium
Company Announcements
Nurix Highlights Promising Phase 1b Data for Bexobrutideg
4M ago
8K
NRIX
Morgan Stanley’s Terence Flynn Reiterates Buy on Nurix, Citing Value-Creating Roche Partnership and Long‑Term Bexobrutideg Growth Potential
Premium
Ratings
Morgan Stanley’s Terence Flynn Reiterates Buy on Nurix, Citing Value-Creating Roche Partnership and Long‑Term Bexobrutideg Growth Potential
4M ago
NRIX
Nurix and Roche forge global BTK degrader alliance
Premium
Company Announcements
Nurix and Roche forge global BTK degrader alliance
4M ago
8K
NRIX
Nurix Therapeutics Stock (NRIX) Soars 40% After $2.3B Blood Cancer Deal with Roche
Premium
Market News
Nurix Therapeutics Stock (NRIX) Soars 40% After $2.3B Blood Cancer Deal with Roche
4M ago
NRIX
More NRIX News >

NRIX News on the Web

Nurix Therapeutics Inc at Morgan Stanley Global Healthcare Conference Transcript
GuruFocus News
Neutral
Nurix Therapeutics price target raised to $34 from $30 at Mizuho
TipRanks News
Bullish
Nurix Therapeutics (NRIX) Receives a Buy from Stifel Nicolaus
TipRanks News
Bullish
Analysts Offer Insights on Healthcare Companies: TruBridge (TBRG), AbbVie (ABBV) and Nurix Therapeutics (NRIX)
TipRanks News
Bullish
Oppenheimer Sticks to Its Buy Rating for Nurix Therapeutics (NRIX)
TipRanks News
Bullish
Nurix Therapeutics price target raised to $40 from $34 at Stifel
TipRanks News
Bullish
Analysts Offer Insights on Healthcare Companies: Nurix Therapeutics (NRIX) and Insulet (PODD)
TipRanks News
Bullish
Analysts Are Bullish on Top Healthcare Stocks: Nurix Therapeutics (NRIX), Johnson & Johnson (JNJ)
TipRanks News
Bullish

News Score - Last 7 Days

Neutral
NRIX
Sector Average
Media Buzz
This Week2 articles
Weekly Average2 articles
News Sentiment
This Week100%
Sector Average91%
See how Bullish or Bearish a stock is based on its recent media coverage.

This score is generated using a formula that combines Media Buzz and News Sentiment.

Media Coverage Analysis

The historical news coverage of this asset in the last three months.

FAQ

What is NRIX’s Media Buzz Sentiment?
2 articles about NRIX were published this week. In an average week, 2 articles are published.
    What is NRIX’s weekly average amount of articles?
    In an average week, 2 articles about NRIX are published.
      What is NRIX’s News Sentiment?
      100% of articles about NRIX were positive this week, compared to its sector average of 91%.
        Healthcare Stocks that are Trending in the News
        XERSXeris Pharmaceuticals
        LGNDLigand Pharma
        MIRMMirum Pharmaceuticals
        AXSMAxsome Therapeutics
        ABBVAbbVie
        Showing the stocks with the most bullish news sentiment over the past week